Hem › Alzheimers sjukdom › Michigan
Kliniska studier för Alzheimers sjukdom i Michigan
15 studier för Alzheimers sjukdom söker deltagare vid platser i Michigan.
Städer i Michigan
Officiell studietext (engelska)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1620, Troy
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Quest Research Institute, Farmington Hills
RekryterarFas 4
Ålder 50 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07633470A Study of LY3439539 in Participants With Alzheimer's Disease
- QUEST Research Institute, Farmington Hills
RekryterarFas 1
Ålder 50 till 85 · Alla kön · Uppdaterad 24 sep. 2026 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
RekryterarFas 2
Ålder 55 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Neurobehavioral Medicine Group (NBMG), Bloomfield Township
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Quest Research Institute, Farmington Hills
RekryterarFas 3
Ålder 50 till 90 · Alla kön · Uppdaterad 21 sep. 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- QUEST Research Institute, Farmington Hills
RekryterarFas 3
Ålder 60 till 85 · Alla kön · Uppdaterad 17 sep. 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- NeuroBehavioral Medicine Group, Bloomfield Hills
- Oakland Medical Research, Troy
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07011732Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Michigan Medicine, Ann Arbor
Rekryterar
Ålder 70 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT05929703Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0088, Sterling Heights
RekryterarFas 2
Ålder 55 till 90 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06808984Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06563895Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- Shiawasee Health Department, Corunna
- McLaren Flint OB-GYN, Flint
- Munson Gaylord OB-GYN, Gaylord
- och 5 fler
Rekryterar
Ålder 18 och äldre · Kvinnor · Uppdaterad 24 juli 2026 · NCT07213284A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Revival Research Institute, LLC, Southfield
RekryterarFas 3
Ålder 55 och äldre · Alla kön · Uppdaterad 7 juli 2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- QUEST Research Institute, Farmington Hills
RekryterarFas 1Friska volontärer välkomna
Ålder 45 till 85 · Alla kön · Uppdaterad 4 juni 2026 · NCT06657768Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Quest Research Institute, Farmington Hills
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 60 till 90 · Alla kön · Uppdaterad 15 apr. 2026 · NCT06584357Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.